Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on CN116655510B. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel copper-catalyzed route offers high-purity anti-cancer intermediates with reduced toxicity and scalable manufacturing potential for global supply chains.